Objective: To assess the safety of the super-mini percutaneous nephrolithotomy (SMP) versus the minimally invasive percutaneous nephrolithotomy (MPCNL) in the treatment of pediatric renal calculus. Methods: We retrospectively reviewed the electronic records of pediatric patients who underwent treatment for renal stones by either SMP or MPCNL from May 2015 to May 2016. We compared the safety of the 2 surgical procedures in the treatment of renal calculus in children by using the generalized estimating equation (GEE) multivariate regression analysis, in which the exposures are the surgical procedures and postoperative adverse events (postoperative complications, fever, and WBC counts) are set as outcome variables. Results: The study included 39 patients (26 boys and 13 girls), of which 22 underwent MPCNL and 17 underwent SMP, with a mean age of 110.05 ± 45.01 and 93.18 ± 41.72 months, respectively. In the univariate logistic regression model, the surgical procedures showed no significant association with postoperative complications (95% CI 0.0–1.5), fever (95% CI 0.1–2.1), postoperative peripheral WBC (95% CI 0.1–2.2). In the multiple logistic regression analysis, there was an insignificant association between surgical methods and postoperative complications (95% CI 0.28–1.1), fever (95% CI 0.1–1.2), and postoperative peripheral WBC (95% CI 0.03–1.8). While using GEE with multiple dependent variables and MPCNL as a reference, the OR of adverse events was 0.15 and the 95% CI were 0.04–0.55. Conclusions: Compared to MPCNL, SMP has a lower incidence of postoperative complications and appears to be a safer treatment for children with kidney stones.

Keywords:
Minimally invasive percutaneous nephrolithotomy, Super-mini percutaneous nephrolithotomy, Pediatric renal calculus, Safety, Efficacy
1.
Mahmud M, Zaidi Z. Percutaneous nephrolithotomy in children before school age: experience of a Pakistani centre.
BJU Int
. 2004 Dec;94(9):1352–4.
2.
Hu L, Shi X, Qing W. Clinical analysis of 224 cases of infants with urinary calculi.
Zhonghua Linchuang Yishi Zazhi
. 2010;4(10):2033–6.
3.
Lottmann HB, Traxer O, Archambaud F, Mercier-Pageyral B. Monotherapy extracorporeal shock wave lithotripsy for the treatment of staghorn calculi in children.
J Urol
. 2001 Jun;165(6 Pt 2):2324–7.
4.
Zhang H, Hong TY, Li G, et al. Comparison of the Efficacy of Ultra-Mini PCNL, Flexible Ureteroscopy, and Shock Wave Lithotripsy on the Treatment of 1-2 cm Lower Pole Renal Calculi.
Urol Int
. 2019;102(2):153–159.
5.
Resorlu B, Unsal A, Tepeler A, Atis G, Tokatli Z, Oztuna D, et al. Comparison of retrograde intrarenal surgery and mini-percutaneous nephrolithotomy in children with moderate-size kidney stones: results of multi-institutional analysis.
Urology
. 2012 Sep;80(3):519–23.
6.
Woodside JR, Stevens GF, Stark GL, Borden TA, Ball WS. Percutaneous stone removal in children.
J Urol
. 1985 Dec;134(6):1166–7.
7.
Choong S, Whitfield H, Duffy P, Kellett M, Cuckow P, Van’t Hoff W, et al. The management of paediatric urolithiasis.
BJU Int
. 2000 Nov;86(7):857–60.
8.
Ng CF. The effect of age on outcomes in -patients undergoing treatment for renal stones.
Curr Opin Urol
. 2009 Mar;19(2):211–4.
9.
Wu K, Xun L, Jian Y, et al. Management of staghorn stones by two stage anti ureter lithotripsy through the mini nephrostomy.
Journal of Guangzhou Medical College.
1993;21(2):13–6.
10.
Xiang S, Wang S, Ce Z, et al. Analysis of curative effect (1120 cases).
China Journal of Endoscopy.
2010;16(4):435–7.
11.
Xun L. minimally invasive philosophic percutaneous nephrolithotomy.
Chin J Endourology
. 2010;4(3):176–9.
12.
Zeng G, Wan S, Zhao Z, Zhu J, Tuerxun A, Song C, et al. Super-mini percutaneous nephrolithotomy (SMP): a new concept in technique and instrumentation.
BJU Int
. 2016 Apr;117(4):655–61.
13.
Tekgül S. Ureteroscopy versus shock wave lithotripsy for renal calculi in children.
J Urol
. 2011 Apr;185(4):1188–9.
14.
D’Addessi A, Bongiovanni L, Sasso F, Gulino G, Falabella R, Bassi P. Extracorporeal shockwave lithotripsy in pediatrics.
J Endourol
. 2008 Jan;22(1):1–12.
15.
Zhao Z, Jia J, Wu W, et al. A comparison of MPCNL and ESWL for renal calculi in infants.
Journal of Mininally Invasive Urology.
2013;2(3):198–201.
16.
Lahme S. Shockwave lithotripsy and endourological stone treatment in children.
Urol Res
. 2006 Apr;34(2):112–7.
17.
Zeng G, Mai Z, Zhao Z, Li X, Zhong W, Yuan J, et al. Treatment of upper urinary calculi  with Chinese minimally invasive percutaneous nephrolithotomy: a single-center experience with 12,482 consecutive patients over 20 years.
Urolithiasis
. 2013 Jun;41(3):225–9.
18.
Desai J, Zeng G, Zhao Z, Zhong W, Chen W, Wu W. A novel technique of ultra-mini-percutaneous nephrolithotomy: introduction and an initial experience for treatment of upper urinary calculi less than 2 cm.
BioMed Res Int
. 2013;2013:490793.
19.
Desai MR, Sharma R, Mishra S, Sabnis RB, Stief C, Bader M. Single-step percutaneous nephrolithotomy (microperc): the initial clinical report.
J Urol
. 2011 Jul;186(1):140–5.
20.
Dogan B, Atmaca AF, Canda AE, Isgoren AE, Akbulut Z, Balbay MD. Efficiency of percutaneous nephrolithotomy in pediatric patients using adult-type instruments.
Urol Res
. 2012 Jun;40(3):259–62.
21.
Du C, Song L, Wu X, Fan D, Zhu L, Liu S, et al. Suctioning Minimally Invasive Percutaneous Nephrolithotomy with a Patented System Is Effective to Treat Renal Staghorn Calculi: A Prospective Multicenter Study.
Urol Int
. 2018;101(2):143–9.
22.
Liu Y, Jian Y, Liu G, et al. Minimally invasive percutaneous nephrolithotomy in children.
Zhonghua Xiaoerwaike Zazhi
. 2005;26(4):189–91.
23.
Cheng F, Yu W, Zhang X, Yang S, Xia Y, Ruan Y. Minimally invasive tract in percutaneous nephrolithotomy for renal stones.
J Endourol
. 2010 Oct;24(10):1579–82.
24.
Knoll T, Wezel F, Michel MS, Honeck P, Wendt-Nordahl G. Do patients benefit from miniaturized tubeless percutaneous nephrolithotomy? A comparative prospective study.
J Endourol
. 2010 Jul;24(7):1075–9.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.